Oral care. Redistributed.

Rinse.
All of it
goes to
mental
health.

Buckshot is a mouthwash company with zero profit extraction. Every dollar of revenue goes to community and individual mental health initiatives. No executives. No dividends. No VC.

BUCKSHOT ALL REVENUE TO
MENTAL HEALTH
100% of revenue donated
0 dollars to founders
"The oral care industry generates $7B+ annually in the US alone. Not one dollar of it funds mental health. Until now."
The gap we exist to close

Radical Transparency

Every donation published. Every dollar tracked. Monthly public receipts, not annual press releases.

Real Product

Clinically formulated. Actually works. We believe people deserve great oral care AND a clear conscience.

Grassroots Partners

Working with NAMI-affiliated community programs and direct-support organizations. Not big national logos for show.

How the money moves

You buy Buckshot

At market price. Better product than the legacy brands. No charity premium.

Production costs covered

Ingredients, manufacturing, packaging. That's it. No margins, no overhead.

100% to mental health

Every remaining dollar. Distributed to community mental health programs. Monthly.

Big brands use your hygiene routine to fund executive bonuses. Buckshot uses yours to fund mental health.

We're not here to guilt-trip you. We're here because mental health is underfunded, misunderstood, and still carries a stigma that keeps people from getting help. A $7B industry pretends it doesn't exist. We built the company we wanted to see.

This isn't a charity with a product. It's a product company with a conscience. Every bottle of Buckshot you buy funds therapy sessions, crisis lines, peer support programs, and community mental health access.

100% of every dollar, always

Your morning routine
can fund someone's
recovery.

Not someday. Not eventually. Every single bottle.

Buckshot pledges 100% of net revenue to mental health programs in the United States.
Pre-orders opening soon

Be first in line —
mouthwash that gives 100%.

Join the waitlist. No spam. No noise. Just the moment we launch —
and what every bottle means for someone who needs it.

100% nonprofit. 100% of revenue to mental health. Zero founders.

← Back to the blog

How we vet our partner organizations

When we onboard a new partner, the first conversation is the most uncomfortable one. We send the organization a list of questions that takes most teams a week to assemble answers to. We do not apologize for that. The vetting process exists because every dollar of Buckshot revenue crosses their desk, and the donor — our customer — has a right to know what happens next.

The first question is for a transparent funding-flow map. Every grant over $1,000, every restricted fund, every account that receives Buckshot money — we want to see where it lands, when it lands, and what it buys. Some organizations have this on a public dashboard. Some assemble it in a spreadsheet. Some have to build it for the first time because nobody ever asked. The acceptance criterion is the same: a reader with no prior context should be able to follow the dollar from our wire to the program it paid for. If they cannot, the partnership does not move forward.

The second question is about mental-health-program overhead — not the financial kind, the operational kind. What fraction of the clinical staff are licensed? What supervision structure do crisis counselors operate under? What is the documented handoff procedure when a text or call exceeds the responder’s scope? A program with a beautiful website and a thin clinical layer is exactly the kind of program we cannot route donations into. The cost of being wrong in this space is measured in lives, not in brand reputation.

Third, we ask for evidence-based curriculum. Every program we fund has to be able to point at the underlying research base — peer-reviewed where it exists, practitioner consensus where it does not, and an explicit reason for every departure from either. We do not require an RCT for every decision; we do require that the decision be defensible to a clinician who is not in the room.

Two organizations we approached this year did not pass phase two. One passed phase three. None has signed yet. We will write about the first signing when there is one.